このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Acceptability, Feasibility and Impact of Oral HIV Self-testing for Partner Testing Among Kenyan Adolescent Girls Aged 15-19 Years: A Randomized Controlled Trial

2022年7月19日 更新者:University of Pennsylvania
This randomized controlled trial will assess the feasibility, acceptability and impact of the provision of multiple oral-fluid based HIV self-test kits to HIV-negative adolescents aged 15-19 years to promote HIV testing among their sexual partners and couples testing.

調査の概要

詳細な説明

This study will recruit HIV-negative adolescents girls (AG) aged 15-19 years in Siaya County, western Kenya. The study will evaluate the impact of the provision of oral HIV self-testing on uptake of testing among partners of adolescent girls. We will randomize about 300 sexually active AG to either an intervention group that receives multiple oral self-test kits that they can choose to offer to their sexual partner(s) or to a control group that will be given multiple referral coupons that their partners can use for HIV testing at pre-selected HIV testing services (HTS) sites. We will collect data on whether the kits were offered, to whom they were offered, if they were accepted, if they were used and with what results, if known, and if the partners who obtained HIV-positive results sought confirmatory testing. We will also conduct in-depth interviews with a sub-set adolescents to explore their experiences in offering HIV self-testing to their male partners.

This study has 4 specific aims: i) determine whether adolescent girls can safely offer oral HIV self-tests to their partners; ii) assess whether oral self-testing improves uptake of HIV testing among partners of adolescent girls; iii) document adverse events associated with offering oral self-testing to sexual partners of adolescent girls; and iv) qualitatively explore the experiences of adolescent girls when offering self-test kits to their partners.

研究の種類

介入

入学 (実際)

349

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Kisumu、ケニア
        • Impact Research & Development Organization

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

15年~19年 (子、大人)

健康ボランティアの受け入れ

はい

受講資格のある性別

女性

説明

Inclusion Criteria:

  • Female
  • Aged 15-19 years
  • HIV-negative (willing to self-test onsite in the presence of the Research Assistant who is also a trained HIV counselor)
  • Has at least one current sexual partner she expects to meet at least twice in the next 3 months (not necessarily to have sex); this will provide opportunity for the participant to suggest/offer testing.
  • Resides in Siaya County and does not intend to relocate within 6 months from enrollment, to allow follow up to be completed and to conduct IDI with those selected.
  • Willing to be randomized into the partner self-testing or HTS referral groups.
  • Reporting no incident of sexual, physical, emotional, or economic abuse in the last 12 months from the partner she intends to offer (Appendix 4) or refer for testing (Appendix 3) in the next 3 months and does not believe the partner will abuse her if she offers the self-test kits or HTS referral coupon.
  • Has a male partner who has not tested for 6 months or whose HIV status is unknown to her.
  • Agrees to give consent to participate in the study.

Exclusion Criteria:

  • Male
  • HIV-positive
  • Not willing to self-test onsite under in the presence of the Research Assistant
  • Aged <15 years or >19 years
  • Does not have a current sexual partner or does not expect to meet the partner at least twice in the next 3 months
  • Does not reside in Siaya County or intends to relocate within the next 6 months
  • Not interested in obtaining HIV self-tests or HTS referral coupon for purposes of suggesting testing to their sexual partners
  • Reporting an incidence of sexual, physical, emotional or economic abuse in the last 12 months from the partner she would have offered self-test kit or referred for testing, or believes the partner may subject her to sexual, physical, emotional, or economic abuse if she offered them self-test kit or HTS coupon.
  • Has a male partner who tested within the last 6 months.
  • Does not give consent to participate in the study

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Provision of multiple self-tests
Participants randomized to the intervention group will be given 2-3 HIV oral self-tests to offer to their sexual partner(s). The participant will be instructed to encourage their partner to test himself alone [partner testing] or with the participant [couple testing]; the partner will also be given a card with information on testing and a list of facilities where he can go for confirmatory testing. All participants will be encouraged to call a study helpline/hotline in the event of any adverse events that they or their sexual partners experience or if they need further instructions or information
Participants will be given multiple Oraquick Advance HIV-1/2 test kits to distribute to their sexual partners for partner testing or couple testing. Phone interviews will be conducted with the participants to assess whether they provided a HIV self-test to their partner, if the test was used, how it was used (partner testing or couple testing), if the partner disclosed his results, the partner's reaction to the results, and if the partner went for confirmatory testing
介入なし:Referral vouchers for clinic testing
Participants randomized to the control group will be given multiple referral coupons for HIV testing at pre-selected HIV testing services (HTS) sites. The participant will be instructed to give the coupon to their sexual partner(s) and encourage him to go for HIV testing at pre-selected HTS sites, either alone [partner testing] or together with the participant [couple testing]. The coupon will also have information on testing and a list of facilities where he can go for HTS. All participants will be encouraged to call a study helpline/hotline in the event of any adverse events that they or their sexual partners experience or if they need further instructions or information

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
uptake of partner HIV testing
時間枠:3 months
proportion of partners that complete HIV testing
3 months

二次結果の測定

結果測定
メジャーの説明
時間枠
Introduce testing
時間枠:3 months
proportion of participants who introduce testing to their partners
3 months
Partner accept testing
時間枠:3 months
proportion of partners who were offered HIVST or referral coupon and accepted
3 months
Partner testing
時間枠:3 months
proportion of participants who report their partner tested alone
3 months
Couples testing
時間枠:3 months
proportion of participants who report testing with their partner
3 months
Positive partner
時間枠:3 months
proportion of participants who report their partner test result was positive
3 months
linked to care
時間枠:3 months
Proportion of participants who report their partners was linked to care
3 months
Intimate partner violence
時間枠:3 months
proportion of participants in each study group who report intimate partner violence related to HIV testing
3 months
Confirmatory testing for positive HIV self-test
時間枠:3 months
proportion of participants in the intervention group who report their partner tested positive and went for confirmatory testing
3 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Kawango Agot, PhD、Impact Organization & Research Development

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2021年3月2日

一次修了 (実際)

2021年4月19日

研究の完了 (実際)

2021年7月2日

試験登録日

最初に提出

2021年3月16日

QC基準を満たした最初の提出物

2021年3月16日

最初の投稿 (実際)

2021年3月18日

学習記録の更新

投稿された最後の更新 (実際)

2022年7月20日

QC基準を満たした最後の更新が送信されました

2022年7月19日

最終確認日

2022年7月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

3
購読する